IL6 and diabetes mellitus: Consistent with the ELISA results, FGF1 treatment ameliorated diabetes‐induced elevated pro‐inflammatory factors (p‐NF‐κBp65 and IL‐6) and further enhanced the increase in IL‐10 in the liver of db/db mice (Figure 3D‐G).